Perspective Therapeutics, Inc.

CATX · AMEX
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
6/30/2022
Assets
Cash & Equivalents$61,580$9,238$20,993$60,354
Short-Term Investments$165,336$0$22,764$0
Receivables$116$1,175$1,363$1,647
Inventory$0$0$1,409$1,068
Other Curr. Assets$4,128$6,424$6,686$535
Total Curr. Assets$231,160$16,837$53,215$63,604
Property Plant & Equip (Net)$59,536$6,323$2,062$2,615
Goodwill$0$24,062$0$0
Intangibles$50,000$50,354$86$107
Long-Term Investments$0$133$150$0
Tax Assets$0$0$0$0
Other NC Assets$405$182-$2,298$926
Total NC Assets$109,941$81,054$2,298$3,648
Other Assets$0$0$2,578$0
Total Assets$341,101$97,891$58,091$67,252
Liabilities
Payables$10,343$6,909$1,541$847
Short-Term Debt$1,009$95$0$260
Tax Payable$0$0$0$0
Deferred Revenue$1,400$0$0$0
Other Curr. Liab.$5,478$8,660-$406$738
Total Curr. Liab.$18,230$15,664$2,676$1,845
LT Debt$3,053$2,456$0$392
Deferred Rev, NC$26,600$0$0$0
Deferred Tax Liab, NC$2,495$4,592$0$0
Other NC Liab.$55$0$0$624
Total NC Liab.$32,203$7,048$0$1,016
Other Liabilities$0$0$116$0
Cap. Leases$2,385$826$0$652
Total Liabilities$50,433$22,712$3,449$2,861
Equity
Pref Stock$0$0$0$0
Common Stock$70$282$142$142
Retained Earnings-$231,719-$152,440-$105,932-$95,172
AOCI-$51$0$0$0
Other Equity$522,368$227,591$160,432$159,421
Total Equity$290,668$75,179$54,642$64,391
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$341,101$97,891$58,091$67,252
Net Debt-$57,518-$6,687-$20,993-$59,702